ag-1296 has been researched along with Astrocytoma, Grade IV in 2 studies
6,7-dimethoxy-3-phenylquinoxaline: ATP-competitive inhibitor of receptor kinase
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Sciaccaluga, M | 1 |
| D'Alessandro, G | 1 |
| Pagani, F | 1 |
| Ferrara, G | 1 |
| Lopez, N | 1 |
| Warr, T | 1 |
| Gorello, P | 1 |
| Porzia, A | 1 |
| Mainiero, F | 1 |
| Santoro, A | 1 |
| Esposito, V | 1 |
| Cantore, G | 1 |
| Castigli, E | 1 |
| Limatola, C | 1 |
| Watanabe, T | 1 |
| Ohtani, T | 1 |
| Aihara, M | 1 |
| Ishiuchi, S | 1 |
2 other studies available for ag-1296 and Astrocytoma, Grade IV
| Article | Year |
|---|---|
Functional cross talk between CXCR4 and PDGFR on glioblastoma cells is essential for migration.
Topics: Cell Line, Tumor; Chemotaxis; Gene Expression Regulation, Neoplastic; Glioblastoma; Humans; Receptor | 2013 |
Enhanced antitumor effect of YM872 and AG1296 combination treatment on human glioblastoma xenograft models.
Topics: Animals; Antineoplastic Agents; Brain Neoplasms; Cell Line, Tumor; Cell Proliferation; Disease Model | 2013 |